Clinical Trial: Human Urine Sample Collection for Alport Nephropathy Biomarker Studies

Study Status: Terminated
Recruit Status: Terminated
Study Type: Observational

Official Title: Human Urine Sample Collection for Alport Nephropathy Biomarker Studies

Brief Summary:

This is a prospective cross-sectional, observational, single-center study of Alport patients, in which a single, first morning voided urine collection will be acquired and used to validate assays of urine biomarkers that reflect changes in glomerular protein filtration barrier function.

The purpose of this study is to identify biomarkers indicative of changes in glomerular filtration function that occur during the course of proteinuric renal diseases such as Alport nephropathy.

Detailed Summary:
Sponsor: Novartis Pharmaceuticals

Current Primary Outcome:

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Novartis

Dates:
Date Received: May 17, 2012
Date Started: September 2012
Date Completion:
Last Updated: February 10, 2014
Last Verified: February 2014